Geode Capital Management, LLC Infinity Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.46 - $1.21 $28,546 - $75,090	-62,058 Reduced 7.14%	807,517 $448,000
Q2 2022 Aug 12, 2022	SELL	$0.49 - $1.2 $275,404 - $674,458	-562,049 Reduced 39.26%	869,575 $549,000
Q1 2022 May 13, 2022	SELL	$0.85 - $2.4 $170,796 - $482,248	-200,937 Reduced 12.31%	1,431,624 $1.63 Million
Q4 2021 Feb 11, 2022	SELL	$1.86 - $3.36 $188,736 - $340,942	-101,471 Reduced 5.85%	1,632,561 $3.67 Million
Q3 2021 Nov 12, 2021	BUY	$1.52 - $3.82 $485,053 - $1.22 Million	319,114 Added 22.55%	1,734,032 $5.93 Million
Q2 2021 Aug 13, 2021	BUY	$2.66 - $3.47 $1.93 Million - $2.52 Million	726,749 Added 105.61%	1,414,918 $4.23 Million
Q1 2021 May 12, 2021	BUY	$1.98 - $5.36 $604,082 - $1.64 Million	305,092 Added 79.64%	688,169 $2.22 Million
Q4 2020 Feb 12, 2021	BUY	$1.05 - $2.77 $11,777 - $31,071	11,217 Added 3.02%	383,077 $812,000
Q2 2020 Aug 13, 2020	BUY	$0.77 - $1.13 $6,347 - $9,314	8,243 Added 2.27%	371,860 $336,000
Q2 2019 Aug 14, 2019	BUY	$1.43 - $1.87 $13,685 - $17,895	9,570 Added 2.7%	363,617 $654,000
Q3 2018 Nov 13, 2018	BUY	$1.72 - $2.71 $17,550 - $27,652	10,204 Added 2.97%	354,047 $959,000
Q2 2018 Aug 14, 2018	BUY	$1.72 - $2.26 $31,434 - $41,303	18,276 Added 5.61%	343,843 $656,000
Q4 2017 Feb 13, 2018	BUY	$1.22 - $3.73 $72,058 - $220,308	59,064 Added 22.16%	325,567 $660,000
Q3 2017 Nov 14, 2017	SELL	$0.94 - $1.35 $1,593 - $2,288	-1,695 Reduced 0.63%	266,503 $354,000
Q2 2017 Aug 14, 2017	BUY	N/A	268,198	268,198 $421,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.